Niall Igoe

Author Statistics

Papers

Citation

H-Index

i-10 index

Research Field

Design of a Biased Potent Small Molecule Inhibitor of the Bromodomain and PHD Finger-Containing (BRPF) Proteins Suitable for Cellular and in Vivo Studies

Journal of Medicinal Chemistry (2017)

Niall Igoe Elliott D. Bayle Oleg Fedorov C. Tallant P. Savitsky

The BRPF (bromodomain and PHD finger-containing) family are scaffolding proteins important for the recruitment of histone acetyltransferases of the MYST family to chromatin. Evaluation of the BRPF family as a potential drug target is at an early stage although there is an emerging understanding of a role in acute myeloid leukemia (AML). We report the optimization of fragment hit 5b to 13-d as a biased, potent inhibitor of the BRD of the BRPFs with excellent selectivity over nonclass IV BRD proteins. Evaluation of 13-d in a panel of cancer cell lines showed a selective inhibition of proliferation of a subset of AML lines. Pharmacokinetic studies established that 13-d had properties compatible with oral dosing in mouse models of disease (Fpo 49%). We propose that NI-42 (13-d) is a new chemical probe for the BRPFs suitable for cellular and in vivo studies to explore the fundamental biology of these proteins.

PHD finger

BRD4

10.1021/acs.jmedchem.6b01583

Cite

Citations (43)

4‐Cyano‐2‐Methoxybenzenesulfonyl Chloride

Organic Syntheses (2018)

Elliott D. Bayle Niall Igoe Paul V. Fish John Wood

Abstract Procedures yielding O ‐(4‐cyano‐2‐methoxyphenyl) dimethylcarbamothioate ( 1 ) as white crystals, S ‐(4‐cyano‐2‐methoxy‐phenyl)dimethylcarbamothioate ( 2 ) as a pure product, 4‐mercapto‐3‐methoxybenzonitrile ( 3 ) (14.4 g, 90%) as a slightly pungent white solid, and 4‐cyano‐2‐methoxybenzenesulfonyl chloride ( 4 ) as a yellow solid are presented. The chapter concludes with a discussion on sulfonamide functional group and related syntheses.

Sulfonamide

10.1002/0471264229.os094.15

Cite

Citations (0)

Selective Targeting of Bromodomains of the Bromodomain-PHD Fingers Family Impairs Osteoclast Differentiation

ACS Chemical Biology (2017)

Julia Meier C. Tallant Oleg Fedorov Hanna Witwicka Sung‐Yong Hwang

Histone acetyltransferases of the MYST family are recruited to chromatin by BRPF scaffolding proteins. We explored functional consequences and the therapeutic potential of inhibitors targeting acetyl-lysine dependent protein interaction domains (bromodomains) present in BRPF1-3 in bone maintenance. We report three potent and selective inhibitors: one (PFI-4) with high selectivity for the BRPF1B isoform and two pan-BRPF bromodomain inhibitors (OF-1, NI-57). The developed inhibitors displaced BRPF bromodomains from chromatin and did not inhibit cell growth and proliferation. Intriguingly, the inhibitors impaired RANKL-induced differentiation of primary murine bone marrow cells and human primary monocytes into bone resorbing osteoclasts by specifically repressing transcriptional programs required for osteoclastogenesis. The data suggest a key role of BRPF in regulating gene expression during osteoclastogenesis, and the excellent druggability of these bromodomains may lead to new treatment strategies for patients suffering from bone loss or osteolytic malignant bone lesions.

10.1021/acschembio.7b00481

Cite

Citations (48)

Design of a Chemical Probe for the Bromodomain and Plant Homeodomain Finger-Containing (BRPF) Family of Proteins

Journal of Medicinal Chemistry (2017)

Niall Igoe Elliott D. Bayle C. Tallant Oleg Fedorov Julia Meier

The bromodomain and plant homeodomain finger-containing (BRPF) family are scaffolding proteins important for the recruitment of histone acetyltransferases of the MYST family to chromatin. Here, we describe NI-57 (16) as new pan-BRPF chemical probe of the bromodomain (BRD) of the BRPFs. Inhibitor 16 preferentially bound the BRD of BRPF1 and BRPF2 over BRPF3, whereas binding to BRD9 was weaker. Compound 16 has excellent selectivity over nonclass IV BRD proteins. Target engagement of BRPF1B and BRPF2 with 16 was demonstrated in nanoBRET and FRAP assays. The binding of 16 to BRPF1B was rationalized through an X-ray cocrystal structure determination, which showed a flipped binding orientation when compared to previous structures. We report studies that show 16 has functional activity in cellular assays by modulation of the phenotype at low micromolar concentrations in both cancer and inflammatory models. Pharmacokinetic data for 16 was generated in mouse with single dose administration showing favorable oral bioavailability

PHD finger

Cocrystal

10.1021/acs.jmedchem.7b00611

Cite

Citations (31)